Abstract

BackgroundQuinazoline are known to possess different biological activities which among is anti-cancer most especially NSCLC. Epidermal growth factor receptor (EGFR) belongs to the receptor tyrosine kinases (RTKs) family, which is known to be one of the most important therapeutic targets for the treatment of cancer most especially NSCLC.ResultsQSAR modeling was performed to develop a model with high predictive power on some non-small cell lung cancer agents (NSCLC) (EGFRWT inhibitors). The EGFRWT inhibitors were optimized using density functional theory (DFT) method utilizing B3LYP/6-31G* level of theory. Genetic function algorithm (GFA) was used to build five models. Out of these five models, the studied one was selected and reported because of its fitness statistically with the following validation parameters: R2trng = 0.9459, R2adj = 0.9311, Q2cv = 0.8947, R2test = 0.7008, and LOF = 0.1195. The selected model was further subjected to other validation test such as VIF and Y-scrambling test applicability domain and found to be statistically significant. The kind of interactions between five most active EGFRWT inhibitors and EGFRWT enzyme were explored via molecular docking. Molecule 4 was ranked top in comparison to other ligands because it has the highest docking score of − 8.3 kcal/mol. The pharmacokinetics studies indicated that these molecules have good absorption, low toxicity level, and permeability properties because none of them violate the Lipinski’s rule of five.ConclusionA model with a very high predictive power on some EGFRWT inhibitors was developed using QSAR model. The model was validated and found to have good internal and external assessment parameters: R2 of 0.9459, R2adj of 0.9311, Qcv2 of 0.8947, R2test of 0.7008, and LOF of 0.1195. The nature of interaction of these molecules with their target protein was explored via molecular docking and found molecule 4 to have the highest docking score of − 8.3 kcal/mol among co-ligands. Pharmacokinetics studies revealed that these molecules have good absorption, low toxicity level, and permeability properties. These findings proposed a way for designing potent EGFRWT inhibitors against their target enzyme.

Highlights

  • Quinazoline are known to possess different biological activities which among is anti-cancer most especially non-small cell lung cancer agents (NSCLC)

  • 3.1 Quantitative structure-activity relationship (QSAR) modeling The results of the QSAR modeling are presented in Tables 1, 2, 3, and 4 and Figs. 1, 2, and 3

  • 4.1 QSAR modeling The studied model was selected and reported because it is statistically fit with the following assessment parameters as compared to other models built: R2 of 0.9459, R2adj of 0.9311, Qcv2 of 0.8947, R2test of 0.7008, and LOF of 0.1195

Read more

Summary

Introduction

Quinazoline are known to possess different biological activities which among is anti-cancer most especially NSCLC. Epidermal growth factor receptor (EGFR) belongs to the receptor tyrosine kinases (RTKs) family, which is known to be one of the most important therapeutic targets for the treatment of cancer most especially NSCLC. Epidermal growth factor receptor (EGFR) from the receptor tyrosine kinases (RTKs) family, is known to be one of the most useful therapeutic targets for the mitigation of cancer most especially NSCLC. It plays a vital role in the regulation of cancer cell survival, migration, growth, proliferation, and differentiation [25, 27]. The second generation was designed to treat EGFRT790M mutations examples are afatinib, dacomitinib and neratinib. While in the case of the third generation, they were developed to treat EGFRT790M/L790M double mutations example AZD9291 [7]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.